W. R. Berkley (AFJK) files Schedule 13G/A showing no Aimei Health ownership

Rhea-AI Filing Summary

W. R. Berkley Corporation filed an amended Schedule 13G/A regarding its position in Aimei Health Technology Co., Ltd, whose securities are ordinary shares with par value $0.0001 per share, CUSIP G01341109.

The filing states that W. R. Berkley Corporation, including subsidiary Berkley Insurance Company, beneficially owns 0 shares of Aimei Health Technology and holds 0.0% of the class. It reports no sole or shared voting or dispositive power over any shares, indicating ownership of five percent or less of the class. The certification is signed by Executive Vice President and Chief Financial Officer, and by Executive Vice President and Treasurer.

Key Figures

Beneficially owned shares: 0 Percent of class: 0.0% Par value per share: $0.0001 per share

3 metrics

Beneficially owned shares 0 Amount beneficially owned in Aimei Health Technology ordinary shares

Percent of class 0.0% Reported percentage of Aimei Health Technology ordinary shares

Par value per share $0.0001 per share Par value of Aimei Health Technology ordinary shares

Key Terms

Schedule 13G/A, beneficially owned, dispositive power, percent of class

4 terms

Schedule 13G/A regulatory

"W. R. Berkley Corporation filed an amended Schedule 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

beneficially owned financial

"Amount beneficially owned: 0"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

dispositive power financial

"Sole Dispositive Power 0.00 8 | Shared Dispositive Power 0.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

percent of class financial

"Percent of class: 0 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/05/2026 - 05:12 PM Accepted by SEC EDGAR 08/05/2026 - 05:11 PM Learn about SEC filing dates

FAQ

What does AFJK’s Schedule 13G/A amendment report about W. R. Berkley’s ownership?

The amendment reports that W. R. Berkley Corporation now beneficially owns 0 shares of Aimei Health Technology (AFJK), representing 0.0% of the class. It also shows no sole or shared voting or dispositive power over any shares.

Which class of AFJK securities is covered in this Schedule 13G/A?

The filing covers Ordinary Shares of Aimei Health Technology Co., Ltd, with a par value of $0.0001 per share and CUSIP number G01341109. These ordinary shares are the class referenced throughout the ownership disclosure.

How much voting power does W. R. Berkley report over AFJK shares?

W. R. Berkley reports 0 sole voting power and 0 shared voting power over Aimei Health Technology’s ordinary shares. It also lists 0 in both sole and shared dispositive power, confirming no control over any reported securities.

What percentage of AFJK’s outstanding shares does W. R. Berkley hold?

The disclosure states that W. R. Berkley Corporation holds 0.0% of the class of Aimei Health Technology’s ordinary shares. This is characterized as ownership of five percent or less of the relevant security class under Schedule 13G rules.

Which W. R. Berkley subsidiary is mentioned in AFJK’s Schedule 13G/A?

The filing identifies Berkley Insurance Company, organized in Delaware, in the ownership structure discussion. An exhibit referenced as Exhibit 99.1 is indicated for further identification and classification details of the subsidiary involved.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Aimei Health Technology Co., Ltd

(Name of Issuer)

Ordinary Shares, par value $0.0001 per share

(Title of Class of Securities)

G01341109

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G01341109

1

Names of Reporting Persons

W. R. Berkley Corporation

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

CUSIP Number(s): G01341109

1

Names of Reporting Persons

Berkley Insurance Company

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.0 %

12

Type of Reporting Person (See Instructions)

CO, IC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Aimei Health Technology Co., Ltd
(b)	Address of issuer's principal executive offices: 10 East 53rd Street, Suite 3001, New York, New York, 10022
Item 2.
(a)	Name of person filing: W. R. Berkley Corporation
(b)	Address or principal business office or, if none, residence: 475 Steamboat Road Greenwich, CT 06830
(c)	Citizenship: US
(d)	Title of class of securities: Ordinary Shares, par value $0.0001 per share
(e)	CUSIP No.: G01341109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 0
(b)	Percent of class: 0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit 99.1
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

W. R. Berkley Corporation

Signature:	/s/ Richard M. Baio
Name/Title:	Richard M. Baio/Executive Vice President and Chief Financial Officer
Date:	08/05/2026

Berkley Insurance Company

Signature:	/s/ Richard M. Baio
Name/Title:	Richard M. Baio/Executive Vice President and Treasurer
Date:	08/05/2026